Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...
The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...
The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...
Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...
Eli Lilly expects its experimental weight loss pill, orforglipron, to receive approval as early as next year, CEO David Ricks told Bloomberg Jan. 13, according to a Wall Street Journal report.
The round is one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market.
U.S. drugmaker Pfizer is going "all in" to develop its experimental obesity drug and has been recruiting more experts in that ...
Rybelsus is a similar drug that's the same price and uses the same ingredient as Ozempic. But Rybelsus is a pill rather than an injection. Wegovy costs $1,349 per month if you pay full price or about ...
Hello, Health Rounds Readers! Today we feature a study that found yet another potential health benefit of GLP-1 drugs, this ...